Medication info

Beacra Duo Syrup [Amoxicillin-Clavulanate Potassium (7:1)]

Prescription medicationSyrupOral
Ingredient · strength
Amoxicillin Hydrate›36.3143g / 100gDilute Potassium Clavulanate›5.1878g / 100g
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
This syrup is a whitish powder with a peculiar smell that dissolves when used.
Packaging
5.5g/50mL
Approval status
Active

MFDS item code 200100662 · Notified 2001.12.12 · Insurance code 694000611

Summary

Main use
Treatment of otorhinolaryngological and respiratory infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
For recurrent tonsillitis and other upper respiratory infections, lower respiratory infections, urinary tract infections, and mild to moderate skin and soft tissue infections, the usual dose is 25 mg/3.6 mg of Amoxicillin/Clavulanate Potassium per kg of body weight, divided into 2 doses per day. For severe infections such as otitis media, sinusitis, bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg of Amoxicillin/Clavulanate Potassium per kg of body weight, divided into 2 doses per day.
Child dose
For mild to moderate infections, including upper respiratory tract infections such as recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg of amoxicillin/potassium clavulanate per kg of body weight per day, divided into 2 doses. For severe infections, including upper respiratory tract infections such as otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg of amoxicillin/potassium clavulanate per kg of body weight per day, divided into 2 doses. The 7 : 1 suspension is not suitable for children under 2 months of age. The 7 : 1 suspension is not suitable for pediatric patients with renal impairment.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of otorhinolaryngological and respiratory infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacteria including Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, and Neisseria gonorrhoeae and is used to treat respiratory diseases such as acute and chronic bronchitis, pneumonia, empyema, tonsillitis, sinusitis, and otitis media. It is also effective for urinary tract infections such as cystitis, urethritis, and pyelonephritis, as well as pelvic infections and sexually transmitted diseases such as gonorrhea. It is helpful in treating a wide range of bacterial infections including skin and soft tissue infections, wound infections, osteomyelitis, and dental infections. Thus, it is used as an antibiotic that is effective against various bacteria for the treatment of infections.

How to take

Adult dose

For recurrent tonsillitis and other upper respiratory infections, lower respiratory infections, urinary tract infections, and mild to moderate skin and soft tissue infections, the usual dose is 25 mg/3.6 mg of Amoxicillin/Clavulanate Potassium per kg of body weight, divided into 2 doses per day. For severe infections such as otitis media, sinusitis, bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg of Amoxicillin/Clavulanate Potassium per kg of body weight, divided into 2 doses per day.

Child dose

For mild to moderate infections, including upper respiratory tract infections such as recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg of amoxicillin/potassium clavulanate per kg of body weight per day, divided into 2 doses. For severe infections, including upper respiratory tract infections such as otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg of amoxicillin/potassium clavulanate per kg of body weight per day, divided into 2 doses. The 7 : 1 suspension is not suitable for children under 2 months of age. The 7 : 1 suspension is not suitable for pediatric patients with renal impairment.

Precautions

This medication contains an artificial sweetener called aspartame, and should be limited in patients with the genetic disorder phenylketonuria. This medication should not be used in patients with a history of hypersensitivity to its ingredients or beta-lactam antibiotics, patients with infectious mononucleosis or lymphocytic leukemia, and patients with a history of liver dysfunction. Patients with impaired liver function or moderate to severe kidney dysfunction, patients with allergic constitution, patients who have difficulty with oral intake, elderly patients, and patients with gastrointestinal diseases should use this medication with caution. During use, gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain may appear, and in severe cases, serious conditions such as pseudomembranous colitis may occur, so if symptoms worsen, the medication should be discontinued immediately, and medical attention should be sought. Symptoms of liver dysfunction may appear rarely, especially in patients over 60 or those on long-term use, so regular liver function tests are recommended. Allergic reactions such as skin rashes, itching, and shortness of breath may occur, so if these symptoms appear, the medication should be discontinued immediately and medical consultation should be sought. Abnormalities such as leukopenia or thrombocytopenia may rarely be reported in blood tests, so blood status should be monitored periodically during long-term use. The safety of this medication during pregnancy and breastfeeding has not been sufficiently confirmed, so it should be avoided particularly during the first three months of pregnancy, and breastfeeding mothers should be cautious due to potential side effects in the baby. This medication may interact with other drugs, so if taking other medications, patients must inform their doctor or pharmacist, particularly with regard to anticoagulants or other antibiotics. In case of overdose, symptoms such as gastrointestinal symptoms, kidney dysfunction, and seizures may occur, so immediate medical attention is required. This medication must be stored in a sealed container as it can be sensitive to air and moisture. It should be kept in a cool place at temperatures between 1 and 25 degrees Celsius and used within 7 days after preparation, shaking well before use.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis accompanied by bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, dyspnea accompanied by bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal pain, increased secretion, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, anticholinergic tremor, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, tooth discoloration, linear IgA disease, dysgeusia, malaise, dermatitis, oral swelling, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsions, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture and should be stored in a sealed container. It is advisable to maintain a storage temperature in a cool place between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

This syrup is a whitish powder with a peculiar smell that dissolves when used.

Package unit

5.5g/50mL

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.